About Structured Immunity

About company

Structured Immunity is a protein engineering company determined to improve the safety of T cell based therapies by increasing the target specificity of T cell receptors. Structured Immunity’s mission is to improve the safety and effectiveness of T cell receptor based therapies. The technology behind Structured Immunity stems from over 20 years of research within the laboratory of Brian Baker. David Hardwicke and Timothy Riley thus founded Structured Immunity in 2017 to provide global expertise in structural immunology and the most advanced structure based TCR optimization platform available today.